In vivo modulation of benzodiazepine receptor function after inhibition of endogenous gamma-aminobutyyric acid synthesis

Eur J Pharmacol. 1997 Feb 19;321(1):13-7. doi: 10.1016/s0014-2999(97)00004-6.

Abstract

The influence of decreased endogenous gamma-aminobutyric acid (GABA) concentration on benzodiazepine receptor function was studied in the brain of living baboons. Positron emission tomography and the radiotracer [11C]flumazenil combined with electroencephalography were used to determine the pharmacological properties of two bezodiazepine receptors agonists, diazepam and bretazenil, in baboons pre-treated or not with DL-allylglycine (an inhibitor of GABA synthesis). Our results show that, in vivo, DL-allylglycine reduces the affinity of benzodiazepine receptors for their agonists without altering the intrinsic capability of agonists to allosterically modulate GABAergic transmission.

MeSH terms

  • Allylglycine / pharmacology
  • Animals
  • Binding, Competitive / drug effects
  • Brain / metabolism
  • Convulsants / pharmacology
  • Diazepam / pharmacology
  • Electroencephalography / drug effects
  • Flumazenil / pharmacokinetics
  • GABA Agonists / pharmacology
  • GABA Antagonists / pharmacology
  • GABA Modulators / pharmacokinetics
  • GABA Modulators / pharmacology
  • GABA-A Receptor Agonists*
  • Ligands
  • Male
  • Papio
  • Pentylenetetrazole / pharmacology
  • Tomography, Emission-Computed
  • gamma-Aminobutyric Acid / biosynthesis*

Substances

  • Convulsants
  • GABA Agonists
  • GABA Antagonists
  • GABA Modulators
  • GABA-A Receptor Agonists
  • Ligands
  • Allylglycine
  • Flumazenil
  • gamma-Aminobutyric Acid
  • Diazepam
  • Pentylenetetrazole